230 related articles for article (PubMed ID: 31314797)
21. Comorbidity in Adult Patients Hospitalized with Type 2 Diabetes in Northeast China: An Analysis of Hospital Discharge Data from 2002 to 2013.
Chen H; Zhang Y; Wu D; Gong C; Pan Q; Dong X; Wu Y; Zhang K; Wang S; Lei J; Xu H
Biomed Res Int; 2016; 2016():1671965. PubMed ID: 27847807
[TBL] [Abstract][Full Text] [Related]
22. Prescribed drugs and polypharmacy in healthcare service users in South Korea: an analysis based on National Health Insurance Claims data.
Park HY; Ryu HN; Shim MK; Sohn HS; Kwon JW
Int J Clin Pharmacol Ther; 2016 May; 54(5):369-77. PubMed ID: 27007996
[TBL] [Abstract][Full Text] [Related]
23. Polypharmacy and comorbidities among ambulatory cancer patients: A cross-sectional retrospective study.
Alwhaibi M; AlRuthia Y; Alhawassi TM; Almalag H; Alsalloum H; Balkhi B
J Oncol Pharm Pract; 2020 Jul; 26(5):1052-1059. PubMed ID: 31619132
[TBL] [Abstract][Full Text] [Related]
24. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
25. Mediterranean diet, walking outdoors and polypharmacy in older patients with type II diabetes.
Fortes C; Mastroeni S; Tubili C; Gianni S; Pandolfo MM; Fano V
Eur J Public Health; 2021 Oct; 31(4):829-835. PubMed ID: 34499712
[TBL] [Abstract][Full Text] [Related]
26. Quality of sleep and risk for obstructive sleep apnoea in ambulant individuals with type 2 diabetes mellitus at a tertiary referral hospital in Kenya: a cross-sectional, comparative study.
Sokwalla SM; Joshi MD; Amayo EO; Acharya K; Mecha JO; Mutai KK
BMC Endocr Disord; 2017 Feb; 17(1):7. PubMed ID: 28166768
[TBL] [Abstract][Full Text] [Related]
27. Polypharmacy in Type 2 Diabetes Mellitus: Insights from an Internal Medicine Department.
Dobrică EC; Găman MA; Cozma MA; Bratu OG; Pantea Stoian A; Diaconu CC
Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31382651
[TBL] [Abstract][Full Text] [Related]
28. Polypharmacy in the general population of a Northern Italian area: analysis of administrative data.
Valent F
Ann Ist Super Sanita; 2019; 55(3):233-239. PubMed ID: 31553315
[TBL] [Abstract][Full Text] [Related]
29. Predictors of polypharmacy among elderly Thais with depressive and anxiety disorders: findings from the DAS study.
Wongpakaran N; Wongpakaran T; Sirirak T; Jenraumjit R; Jiraniramai S; Lerttrakarnnon P
BMC Geriatr; 2018 Dec; 18(1):309. PubMed ID: 30541459
[TBL] [Abstract][Full Text] [Related]
30. Polypharmacy in elderly patients with type 2 diabetes receiving oral antidiabetic treatment.
Noale M; Veronese N; Cavallo Perin P; Pilotto A; Tiengo A; Crepaldi G; Maggi S
Acta Diabetol; 2016 Apr; 53(2):323-30. PubMed ID: 26155958
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with appropriate knowledge of the indications for prescribed drugs among community-dwelling older patients with polypharmacy.
Bosch-Lenders D; Maessen DW; Stoffers HE; Knottnerus JA; Winkens B; van den Akker M
Age Ageing; 2016 May; 45(3):402-8. PubMed ID: 27013501
[TBL] [Abstract][Full Text] [Related]
32. Prescription of potentially inappropriate medication in Korean older adults based on 2012 Beers Criteria: a cross-sectional population based study.
Nam YS; Han JS; Kim JY; Bae WK; Lee K
BMC Geriatr; 2016 Jun; 16():118. PubMed ID: 27255674
[TBL] [Abstract][Full Text] [Related]
33. Optimizing drug therapy in frail patients with type 2 diabetes mellitus.
Molist-Brunet N; Sevilla-Sánchez D; Puigoriol-Juvanteny E; González-Bueno J; Solà-Bonada N; Cruz-Grullón M; Espaulella-Panicot J
Aging Clin Exp Res; 2020 Aug; 32(8):1551-1559. PubMed ID: 31494916
[TBL] [Abstract][Full Text] [Related]
34. Review of prescription medications in home-based older adults with stroke: a pilot study.
Classen S; Meuleman J; Garvan C; Ried LD; Mann W; Asal N
Res Social Adm Pharm; 2007 Mar; 3(1):104-22. PubMed ID: 17350560
[TBL] [Abstract][Full Text] [Related]
35. The practice of polypharmacy involving herbal and prescription medicines in the treatment of diabetes mellitus, hypertension and gastrointestinal disorders in Jamaica.
Delgoda R; Ellington C; Barrett S; Gordon N; Clarke N; Younger N
West Indian Med J; 2004 Dec; 53(6):400-5. PubMed ID: 15816268
[TBL] [Abstract][Full Text] [Related]
36. Younger-onset versus older-onset type 2 diabetes: Clinical profile and complications.
Unnikrishnan R; Anjana RM; Amutha A; Ranjani H; Jebarani S; Ali MK; Narayan K; Mohan V
J Diabetes Complications; 2017 Jun; 31(6):971-975. PubMed ID: 28410927
[TBL] [Abstract][Full Text] [Related]
37. Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database.
Zhang Q; Rajagopalan S; Mavros P; Engel SS; Davies MJ; Yin D; Radican L
Curr Med Res Opin; 2010 Jul; 26(7):1697-703. PubMed ID: 20465367
[TBL] [Abstract][Full Text] [Related]
38. The management of diabetic ketoacidosis at a rural regional hospital in KwaZulu-Natal.
Ndebele NFM; Naidoo M
Afr J Prim Health Care Fam Med; 2018 Mar; 10(1):e1-e6. PubMed ID: 29781681
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and predictors of polypharmacy in Jordanian hospitalised patients: A cross-sectional Study.
Abu Farha RK; Mukattash TL; Al-Sakran L; Abu Hammour K; Zawiah M
Int J Clin Pract; 2021 Apr; 75(4):e13742. PubMed ID: 32991028
[TBL] [Abstract][Full Text] [Related]
40. Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM).
Kumar SS; McManus H; Radovich T; Greenfield JR; Viardot A; Williams KM; Cronin P; Day RO
Eur J Clin Pharmacol; 2018 Oct; 74(10):1327-1332. PubMed ID: 29938343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
